2.6
2.60 (0.65%)
As of Mar 06, 2024
Minerva Neurosciences, Inc. [NERV]
Source:
Company Overview
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of proprietary product candidates to treat patients suffering from central nervous system (“CNS”) diseases.
Country | United States |
Headquarters | waltham, massachusetts |
Phone Number | 617-600-7373 |
Industry | manufacturing |
CEO | Remy Luthringer, Ph.D. |
Website | www.minervaneurosciences.com |